Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Vannier

Showing results (121-130 of 180) with videos related to

Pageof 18
Sort By:
Annales Pharmaceutiques Francaises|August 18, 2004
[Protein Z: a new regulator of coagulation in arterial vessels?]M Vasse, Chr Denoyelle, E Guégan-Massardier, et al.
Bone Marrow Transplantation|January 1, 1993
Bone marrow transplantation (BMT) in 14 children with severe sickle cell disease (SCD): the French experience. GEGMOF Bernaudin, G Souillet, J P Vannier, et al.
Medical and Pediatric Oncology|January 1, 1994
Treatment of relapsed or refractory acute leukemia in childhood with bisantrene combined with high dose aracytineT Leblanc, F Deméocq, G Leverger, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|July 26, 2002
Oncostatin M induces procoagulant activity in human vascular smooth muscle cells by modulating the balance between tissue factor and tissue factor pathway inhibitorF Mirshahi, M Vasse, A Tedgui, et al.
Annals of the New York Academy of Sciences|July 20, 2001
Fibrinogen: a vascular risk factor, why? Contributing effect of oncostatin M on both fibrinogen biosynthesis by hepatocytes and participation in atherothrombotic risk related to modifications of endothelial cellsF Mirshahi, M Vasse, L Vincent, et al.
Biology of the Neonate|June 12, 1999
Erythropoietin blood level is increased in sudden infant deathV Le Cam-Duchez, A Coquerel, F Chevallier, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1990
New evaluations of circulating granulocyte and macrophage stem cells in healthy adults using conditioned media and recombinant human growth factorsJ P Vannier, E Sumereau-Dassin, P Jean, et al.
Nouvelle Revue Francaise D'Hematologie|June 1, 1993
[Treatment of severe forms of sickle cell anemia with bone marrow allograft: French experience (15 cases). SFGM]F Bernaudin, G Souillet, J P Vannier, et al.
Medical and Pediatric Oncology|January 1, 1991
Pancreatoblastoma: response to chemotherapyJ P Vannier, F Flamant, J Hemet, et al.
Contraception, Fertilite, Sexualite (1992)|April 7, 1999
[Malignant non-seminomatous germinal tumors of the ovary. Experience of the French Society of Pediatric Oncology. 64 cases]M C Baranzelli, C Patte, E Bouffet, et al.
Pageof 18

Showing results (121-130 of 180) with videos related to

Sort By:
Pageof 18
Annales Pharmaceutiques Francaises|August 18, 2004
[Protein Z: a new regulator of coagulation in arterial vessels?]M Vasse, Chr Denoyelle, E Guégan-Massardier, et al.
Bone Marrow Transplantation|January 1, 1993
Bone marrow transplantation (BMT) in 14 children with severe sickle cell disease (SCD): the French experience. GEGMOF Bernaudin, G Souillet, J P Vannier, et al.
Medical and Pediatric Oncology|January 1, 1994
Treatment of relapsed or refractory acute leukemia in childhood with bisantrene combined with high dose aracytineT Leblanc, F Deméocq, G Leverger, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|July 26, 2002
Oncostatin M induces procoagulant activity in human vascular smooth muscle cells by modulating the balance between tissue factor and tissue factor pathway inhibitorF Mirshahi, M Vasse, A Tedgui, et al.
Annals of the New York Academy of Sciences|July 20, 2001
Fibrinogen: a vascular risk factor, why? Contributing effect of oncostatin M on both fibrinogen biosynthesis by hepatocytes and participation in atherothrombotic risk related to modifications of endothelial cellsF Mirshahi, M Vasse, L Vincent, et al.
Biology of the Neonate|June 12, 1999
Erythropoietin blood level is increased in sudden infant deathV Le Cam-Duchez, A Coquerel, F Chevallier, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1990
New evaluations of circulating granulocyte and macrophage stem cells in healthy adults using conditioned media and recombinant human growth factorsJ P Vannier, E Sumereau-Dassin, P Jean, et al.
Nouvelle Revue Francaise D'Hematologie|June 1, 1993
[Treatment of severe forms of sickle cell anemia with bone marrow allograft: French experience (15 cases). SFGM]F Bernaudin, G Souillet, J P Vannier, et al.
Medical and Pediatric Oncology|January 1, 1991
Pancreatoblastoma: response to chemotherapyJ P Vannier, F Flamant, J Hemet, et al.
Contraception, Fertilite, Sexualite (1992)|April 7, 1999
[Malignant non-seminomatous germinal tumors of the ovary. Experience of the French Society of Pediatric Oncology. 64 cases]M C Baranzelli, C Patte, E Bouffet, et al.
Pageof 18